Propranolol – Potential under-recognised risk of harm

The Healthcare Safety Investigation Branch (HSIB) has conducted a patient safety investigation that explores the under recognised toxicity of propranolol in overdose.

The investigation looks at awareness of the toxicity of propranolol, ambulance response to overdose calls, and the treatment of patients who have overdosed.

Full details of the report and specific recommendations can be found here

speak to a member of our expert team at Speeds Healthcare CONTACT US